[HTML][HTML] The development of New Delhi metallo-β-lactamase-1 inhibitors since 2018

X Gu, M Zheng, L Chen, H Li - Microbiological Research, 2022 - Elsevier
New Delhi metallo-β-lactamase-1 (NDM-1) can hydrolyze almost all antibiotics of the β-
lactam group, resulting in the generation of multidrug resistant bacteria. Besides its broad …

Recent advances in β-lactamase inhibitor chemotypes and inhibition modes

R Li, X Chen, C Zhou, QQ Dai, L Yang - European journal of medicinal …, 2022 - Elsevier
The effectiveness of β-lactam antibiotics is increasingly influenced by serine β-lactamases
(SBLs) and metallo-β-lactamases (MBLs), which can hydrolyze β-lactam antibiotics. The …

Optimization of 1, 2, 4-triazole-3-thiones toward broad-spectrum metallo-β-lactamase inhibitors showing potent synergistic activity on VIM-and NDM-1-producing …

A Legru, F Verdirosa, Y Vo-Hoang… - Journal of Medicinal …, 2022 - ACS Publications
Metallo-β-lactamases (MBLs) contribute to the resistance of Gram-negative bacteria to
carbapenems, last-resort antibiotics at hospital, and MBL inhibitors are urgently needed to …

Bismuth complex of quinoline thiosemicarbazone restores carbapenem sensitivity in NDM-1-positive Klebsiella pneumoniae

M Scaccaglia, M Rega, C Bacci, D Giovanardi… - Journal of Inorganic …, 2022 - Elsevier
Resistant bacteria represent an urgent worldwide threat. NDM-1-producing strains are
rendering the last line antibiotics less effective. Six bismuth complexes of general formula …

1, 2, 4-Triazole-3-thione compounds with a 4-ethyl alkyl/aryl sulfide substituent are broad-spectrum metallo-β-lactamase inhibitors with re-sensitization activity

A Legru, F Verdirosa, JF Hernandez, G Tassone… - European Journal of …, 2021 - Elsevier
Abstract Metallo-β-lactamases (MBLs) are important contributors of Gram-negative bacteria
resistance to β-lactam antibiotics. MBLs are highly worrying because of their …

4-Alkyl-1, 2, 4-triazole-3-thione analogues as metallo-β-lactamase inhibitors

L Gavara, A Legru, F Verdirosa, L Sevaille, L Nauton… - Bioorganic …, 2021 - Elsevier
In Gram-negative bacteria, the major mechanism of resistance to β-lactam antibiotics is the
production of one or several β-lactamases (BLs), including the highly worrying …

An updated patent review of metallo-β-lactamase inhibitors (2020–2023)

E Denakpo, T Naas, BI Iorga - Expert Opinion on Therapeutic …, 2023 - Taylor & Francis
ABSTRACT Introduction Metallo-β-lactamases (MBLs) are enzymes produced by bacteria
that confer resistance to most β-lactam antibiotics, including carbapenems, which have the …

[HTML][HTML] Recent developments to cope the antibacterial resistance via β-lactamase inhibition

Z Iqbal, J Sun, H Yang, J Ji, L He, L Zhai, J Ji, P Zhou… - Molecules, 2022 - mdpi.com
Antibacterial resistance towards the β-lactam (BL) drugs is now ubiquitous, and there is a
major global health concern associated with the emergence of new β-lactamases (BLAs) as …

[HTML][HTML] Enzyme inhibitors: the best strategy to tackle superbug NDM-1 and its variants

X Li, D Zhao, W Li, J Sun, X Zhang - International Journal of Molecular …, 2021 - mdpi.com
Multidrug bacterial resistance endangers clinically effective antimicrobial therapy and
continues to cause major public health problems, which have been upgraded to …

[HTML][HTML] Synthesis and Biological Evaluation of New Schiff Bases Derived from 4-Amino-5-(3-fluorophenyl)-1, 2, 4-triazole-3-thione

S Janowska, D Khylyuk, M Janowski, U Kosikowska… - Molecules, 2023 - mdpi.com
The treatment of infectious diseases is a challenging issue faced by the medical community.
The emergence of drug-resistant strains of bacteria and fungi is a major concern …